SABCS 2021 Conference Coverage on VuMedi
Playback speed
10 seconds
SABCS 2021 Update on T-DXd vs.T-DM1 in High-Risk HER2+ Residual Invasive EBC Following Neoadjuvant Therapy: Phase 3 DESTINY-Breast05 Trial
By
SABCS 2021 Conference Coverage on VuMedi
FEATURING
Charles Geyer
By
SABCS 2021 Conference Coverage on VuMedi
FEATURING
Charles Geyer
503 views
December 16, 2021
Comments 0
Login to view comments.
Click here to Login